Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Resistance
New drug resistance research from Orebro University, Department of Clinical Medicine outlined
May 21st, 2008
New research, 'The Neisseria gonorrhoeae population in Sweden during 2005-phenotypes, genotypes and antibiotic resistance,' is the subject of a report. "In Sweden, the gonorrhoea incidence has significantly increased since an all-time low in 1996. We aimed to phenotypically and genotypically characterise N. gonorrhoeae isolates (n=180) transmitted in Sweden during 2005," researchers in Sweden report. "All isolates were susceptible to cefixime, ceftriaxone, and spectinomycin. However, 2%, 50% and 75% displayed intermediate susceptibility or resistance to azithromycin, ciprofloxacin and ampicillin, respectively. The isolates were assigned to 28 different serovars...
Source: Immunotherapy Weekly (2008-05-21)
|
